Moniba, Matranillo B.
HRN: 12-66-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/04/2023
01/10/2023
IV
600mg
Q8h
CAP HR; COPD In AE
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes